Found 5 matching trials
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
PHASE1This study evaluates ADCT-301 in patients with Selected Advanced Solid Tumo...
Location
Stanford Cancer Center
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
PHASE1This study evaluates ADCT-301 in participants with Acute Myeloid Leukemia (...
Location
Winship Cancer Institute, Emory University
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
PHASE1This study evaluates camidanlumab tesirine in participants with relapsed/re...
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma
PHASE2The purpose of this study is to evaluate the clinical efficacy and safety o...
Location
Mayo Clinic - Arizona
ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN
PHASE2This is research study to find out if a drug called ADCT-301 is safe and to...
Location
Duke University Health System